Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-04-13 @ 10:25 PM
Study NCT ID:
NCT00780858
Status:
COMPLETED
Last Update Posted:
2015-05-06
First Post:
2008-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI
Sponsor:
IVI Madrid
Organization:
Study Overview
Official Title:
GnRH Antagonist Prevention of Premature Luteinization in Patients Undergoing IUI
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LP
Brief Summary:
Premature luteinization in patients undergoing IUI can occur in up to 24% of cycles. These patients, according to recent data, have a lower pregnancy rate than controls. The possibility to avoid premature luteinization with GnRH antagonist may restore the chances of achieving a pregnancy in these women.
Detailed Description:
The purpose of this study was to investigate whether a subset of patients benefits from GnRHa administration during IUI. PL was tested for in patients who were undergoing artificial insemination procedures, and the effect of GnRHa on PR in patients who
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: